What is dyne therapeutics? Dyne Therapeutics - A biotechnology company developing nucleic acid therapies for rare diseases. Dyne Therapeutics is building a leading muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases.What is dydyno therapeutics? Dyno Therapeutics is leading a machine learning revolution to develop technologies that dramatically enhance therapies for genetic disease. dy·no. (noun) in climbing, a rapid move across a rock face in order to reach a hold.What is genegene doing at dyne? Gene brings extensive biotechnology-focused finance experience to his role at Dyne. Previously, he served as vice president of finance at Kaleido Biosciences, where he led the build-out of the company’s financial planning and analysis capabilities.How many shares of common stock are being offered by dyne? In addition, Dyne has granted the underwriters a 30-day option to purchase up to 900,000 additional shares of common stock at the public offering price, less the underwriting discount and commissions. All of the shares are being offered by Dyne.
Dyne Therapeutics has 90 employees at their 1 location and $165 m in total funding,. See insights on Dyne Therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.
Dyne Therapeutics Information. Dyne was founded with a singular focus: to transform the lives of people with serious muscle diseases by pioneering muscle-targeted therapies. Our proprietary technologies provide the foundation for breakthrough treatments. We have assembled a world-class team of experts who are united by their commitment to